Search For

Unraveling resistance to immune checkpoint inhibitors in HNSCC: from mechanisms to combination therapies

Osimertinib acquired resistance among patients with EGFR-mutated NSCLC: from molecular mechanisms to clinical therapeutic strategies

Mechanisms of resistance to antibody-drug conjugates in cancer therapy: molecular basis and therapeutic strategies

Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies

New advances in understanding the mechanisms and treatment challenges of ALK-targeted therapy resistance in lung cancer

Decoding breast cancer treatment resistance through genetic, epigenetic, and immune-regulatory mechanisms: from molecular insights to translational perspectives

Antibody-drug conjugates in breast cancer: current resistance mechanisms and future combination strategies

Fibroblast growth factor receptor alterations and resistance mechanisms in the treatment of pediatric solid tumors

Mechanisms of resistance to NAMPT inhibitors in cancer

The epigenetic mechanisms involved in the treatment resistance of glioblastoma

Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencing

Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches